-+ 0.00%
-+ 0.00%
-+ 0.00%

Cytokinetics Grants 64,110 Stock Options, 42,496 RSUs to 18 New Employees

PUBT·11/16/2026 21:00:25
Listen to the news
Cytokinetics Grants 64,110 Stock Options, 42,496 RSUs to 18 New Employees
  • Cytokinetics granted stock options covering 64,110 common shares and 42,496 restricted stock units to 18 employees on November 13, 2026.
  • Recipients began employment in October and November 2026; restricted stock units will settle in common shares upon vesting.
  • Restricted stock units vest over three years: 40% on each of the first two grant anniversaries, then 20% on the third.
  • Stock options vest over four years: 25% after one year, then 1/48 of underlying shares monthly over the next 36 months.
  • Both awards require continued service for vesting; the options have a 10-year term.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cytokinetics Incorporated published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611161600PRIMZONEFULLFEED9878729) on November 16, 2026, and is solely responsible for the information contained therein.